These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12602796)

  • 1. Investigation of physical and hypoglycaemic properties of rectal suppositories with chosen insulin.
    Kosior A
    Acta Pol Pharm; 2002; 59(5):353-8. PubMed ID: 12602796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of hypoglycemic properties of rectal suppositories with chlorpropamide.
    Kosior A
    Acta Pol Pharm; 2002; 59(2):109-13. PubMed ID: 12365601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative hypoglycemic effect of insulin suppositories in diabetic beagle dogs: optimization of various concentrations of sodium salicylate and polyoxyethylene-9-lauryl ether.
    Hosny EA; Al-Shora HI; Elmazar MM
    Biol Pharm Bull; 2001 Nov; 24(11):1294-7. PubMed ID: 11725967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible pegylation of insulin facilitates its prolonged action in vivo.
    Shechter Y; Mironchik M; Rubinraut S; Tsubery H; Sasson K; Marcus Y; Fridkin M
    Eur J Pharm Biopharm; 2008 Sep; 70(1):19-28. PubMed ID: 18495444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium salicylate on insulin rectal absorption in humans.
    Hosny E; el-Ahmady O; el-Shattawy H; Nabih A el-M ; el-Damacy H; Gamal-el-Deen S; el-Kabbany N
    Arzneimittelforschung; 1994 May; 44(5):611-3. PubMed ID: 8024632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of microneedles for percutaneous absorption of insulin.
    Ito Y; Hagiwara E; Saeki A; Sugioka N; Takada K
    Eur J Pharm Sci; 2006 Sep; 29(1):82-8. PubMed ID: 16828268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X
    Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption kinetics of insulin after subcutaneous administration.
    Søeborg T; Rasmussen CH; Mosekilde E; Colding-Jørgensen M
    Eur J Pharm Sci; 2009 Jan; 36(1):78-90. PubMed ID: 19028573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.
    Yun M; Choi H; Jung J; Kim C
    Int J Pharm; 1999 Nov; 189(2):137-45. PubMed ID: 10536242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
    Salmaso S; Bersani S; Elvassore N; Bertucco A; Caliceti P
    Int J Pharm; 2009 Sep; 379(1):51-8. PubMed ID: 19545616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycaemic effect of a novel insulin buccal formulation on rabbits.
    Xu HB; Huang KX; Zhu YS; Gao QH; Wu QZ; Tian WQ; Sheng XQ; Chen ZX; Gao ZH
    Pharmacol Res; 2002 Nov; 46(5):459-67. PubMed ID: 12419651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.
    Zhang X; Zhang H; Wu Z; Wang Z; Niu H; Li C
    Eur J Pharm Biopharm; 2008 Mar; 68(3):526-34. PubMed ID: 17881202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative hypoglycemia of rectal insulin suppositories containing deoxycholic acid, sodium taurocholate, polycarbophil, and their combinations in diabetic rabbits.
    Hosny EA
    Drug Dev Ind Pharm; 1999 Jun; 25(6):745-52. PubMed ID: 10349560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and characterization of an oily-based system for oral delivery of insulin.
    Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.